+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Parvovirus Vaccine Market by Animal Type (Canine, Feline, Porcine), Vaccine Type (Inactivated, Live Attenuated, Recombinant), Distribution Channel, Product Format, End User - Global Forecast 2025-2030- Product Image
Animal Parvovirus Vaccine Market by Animal Type (Canine, Feline, Porcine), Vaccine Type (Inactivated, Live Attenuated, Recombinant), Distribution Channel, Product Format, End User - Global Forecast 2025-2030- Product Image
New

Animal Parvovirus Vaccine Market by Animal Type (Canine, Feline, Porcine), Vaccine Type (Inactivated, Live Attenuated, Recombinant), Distribution Channel, Product Format, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133159
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction to the Strategic Outlook and Critical Considerations Shaping the Animal Parvovirus Vaccine Market's Emerging Opportunities and Challenges

The introduction to this executive summary establishes the critical context for understanding the unique challenges and opportunities within the animal parvovirus vaccine landscape. Animal parvovirus represents one of the most formidable threats to domestic and commercial animal health, affecting species from household pets such as canines and felines to livestock including porcine populations. The virus’s resilience in varied environmental conditions and its capacity for rapid transmission underscore the imperative for robust immunization strategies. This section sets the stage by outlining the driving forces behind vaccine adoption, regulatory considerations, and the overarching significance of safeguarding animal populations against this pervasive pathogen.

Building on this context, the introduction delineates the primary objectives of the analysis. It highlights the need to dissect evolving industry dynamics, from scientific innovations in vaccine development to shifts in supply chain logistics. Moreover, it emphasizes the importance of stakeholder collaboration across veterinary clinics, research institutions, and production facilities to accelerate the deployment of effective prophylactic solutions. With a professional tone aimed at decision-makers and subject matter experts, this introduction primes readers for an in-depth exploration of market shifts, segmentation nuances, regional variances, and strategic imperatives that will be unpacked in the subsequent sections.

Key Drivers and Innovations Redefining the Animal Parvovirus Vaccine Landscape Amidst Technological Advances and Evolving Animal Health Practices

Innovation and emerging trends are redefining the trajectory of animal parvovirus vaccine development. Advances in biotechnology have accelerated the advent of next-generation recombinant platforms, enabling more precise antigen targeting and improved immunogenicity. At the same time, live attenuated vaccines continue to evolve, leveraging refined attenuation techniques that strike a balance between safety and efficacy. This transformation is further catalyzed by enhanced cold chain management solutions, which ensure vaccine integrity from manufacturing sites to remote veterinary clinics and farm locations.

Simultaneously, industry stakeholders are navigating a broader shift toward integrated animal health management. Digital health tools now enable real-time monitoring of herd immunity parameters, tying vaccination efforts to actionable insights on disease prevalence. As a result, manufacturers and distributors are forging new alliances, integrating research and development pipelines with veterinary services to deliver holistic preventive care. Together, these forces are converging to create a more responsive, data-driven ecosystem, where transformative shifts in scientific, logistical, and collaborative frameworks redefine the competitive landscape.

Analyzing the Cumulative Impact of United States Tariffs Introduced in 2025 on Supply Chains, Production Costs, and Global Trade Dynamics for Animal Parvovirus Vaccines

The introduction of United States tariffs in 2025 has reverberated throughout global supply chains for vaccine raw materials and finished products. These trade measures have imposed additional levies on key inputs such as specialized culture media and adjuvant compounds, prompting pricing recalibrations at manufacturing facilities both domestically and abroad. Consequently, production costs have been realigned to accommodate higher import expenses, with downstream effects on distribution agreements and inventory management strategies.

Amid these changes, stakeholders have adapted by diversifying sourcing strategies and optimizing production footprints. Manufacturers are exploring nearshoring options to mitigate tariff-induced cost pressures, while logistics providers renegotiate transportation contracts to secure more favorable terms. At the same time, regulatory agencies have intensified scrutiny on supply chain transparency, urging greater visibility into component provenance and compliance standards. This cumulative impact has underscored the need for agility and foresight, as industry participants recalibrate their operational models to sustain resilience against evolving trade dynamics.

In-Depth Examination of Crucial Market Segmentation by Animal Type, Vaccine Type, Distribution Channels, Product Formats, and End User Applications

A granular understanding of the vaccine landscape hinges on nuanced segmentation across multiple vectors. By animal type, the field encompasses interventions for canine and feline populations as well as porcine segments, with further attention to lifecycle stages spanning adult swine and piglets. Concurrently, vaccine formulations are classified by modality, ranging from traditional inactivated preparations to live attenuated strains and cutting-edge recombinant constructs that deliver targeted immunological responses.

Distribution strategies also diverge between offline channels-including retail pharmacy operations, veterinary clinics, and hospital settings-and online platforms that cater to digital ordering and home delivery. This channel diversity is complemented by variations in product format, where liquid suspensions facilitate rapid administration and lyophilized powders extend shelf life under challenging storage conditions. Finally, end users span large-scale animal farm operations, independent veterinary clinics, and referral veterinary hospitals, each with distinct procurement cycles and clinical protocols. Together, these segmentation insights illuminate the complexities of reaching diverse customer cohorts with tailored vaccine solutions.

Regional Perspectives and Insights on the Animal Parvovirus Vaccine Market Across the Americas, Europe Middle East Africa, and Asia Pacific Regions

Regional dynamics exert a profound influence on vaccine adoption patterns, shaped by factors such as regulatory frameworks, agricultural practices, and healthcare infrastructure. In the Americas, established veterinary networks and large-scale commercial farming drive demand for scalable, rapid-deployment immunization protocols. Stakeholders in North and South America emphasize consistency in supply and alignment with robust safety standards, cultivating an environment where premium vaccine platforms gain traction.

Across Europe, the Middle East, and Africa, heterogeneous regulatory landscapes and variable veterinary resource allocation create divergent growth pathways. Western European markets often prioritize advanced recombinant vaccine technologies, supported by comprehensive animal health policies. In contrast, emerging economies within the Middle East and Africa focus on cost-effective formulations that balance affordability with efficacy. Meanwhile, Asia-Pacific represents a dynamic growth frontier, where expanding livestock farming, rising pet ownership, and increasing investments in cold chain infrastructure spur widespread vaccine utilization. These regional nuances underscore the importance of localized strategies and regulatory alignment.

Comprehensive Profiling of Leading Animal Parvovirus Vaccine Manufacturers and Their Strategic Initiatives Driving Competitive Differentiation

Leading companies in the animal parvovirus vaccine arena have institutionalized innovation as a core strategic pillar. These organizations leverage proprietary research capabilities to refine antigen design and optimize adjuvant combinations, securing competitive differentiation through improved safety profiles and immunogenic performance. Strategic partnerships with academic centers and contract research organizations further accelerate the translation of laboratory breakthroughs into scalable production pipelines.

Beyond product development, key players are investing in integrated supply networks that enhance responsiveness to fluctuating demand. This includes expanding contract manufacturing capacity in strategically located facilities and forging distribution alliances that extend reach into underserved markets. In parallel, digital engagement platforms facilitate direct collaboration with veterinary professionals, enabling real-time feedback loops that inform iterative improvements. Collectively, these strategic initiatives underscore a commitment to fortifying market positioning through continuous innovation, operational excellence, and customer-centric engagement.

Actionable Strategic Recommendations for Industry Leaders to Navigate Market Challenges and Capitalize on Emerging Opportunities in Animal Parvovirus Vaccination

Industry leaders can harness several strategic imperatives to strengthen their market position and propel sustainable growth. First, prioritizing platform technologies that enable rapid vaccine adaptation will be critical in responding to emerging viral strains and regulatory shifts. Concurrently, investing in modular manufacturing capabilities can reduce time to market while preserving quality assurance across diverse product formats.

Second, cultivating collaborative partnerships across the value chain-from raw material suppliers to veterinary services-will enhance supply chain resilience and streamline distribution pathways. Third, deploying data-driven market intelligence tools can refine demand forecasting methodologies and optimize inventory management, even as trade dynamics evolve. Finally, embracing digital engagement with end users through telehealth consultations and e-commerce channels can deepen customer relationships and facilitate personalized vaccine solutions. Collectively, these actionable recommendations offer a roadmap for organizations seeking to navigate complex industry headwinds and capitalize on emerging growth opportunities.

Methodological Framework and Research Approach Underpinning the Analysis of the Animal Parvovirus Vaccine Market Study with Emphasis on Data Integrity and Validation

The research methodology underpinning this report integrates a multi-layered approach to ensure analytical rigor and data integrity. Primary research involved in-depth interviews with subject matter experts, including veterinary clinicians, supply chain managers, and R&D specialists. These qualitative insights were complemented by a systematic review of regulatory filings, scientific publications, and policy documentation to validate industry trends and technological advancements.

Secondary research drew upon proprietary databases and public domain sources to construct a comprehensive data foundation. Triangulation techniques were applied to reconcile divergent data points, while sensitivity analyses tested the robustness of key assumptions. Throughout the process, adherence to stringent quality control protocols-encompassing data validation checks and peer reviews-ensured the reliability of findings. This methodological framework provides a transparent and reproducible basis for the strategic insights presented in the executive summary.

Synthesis of Key Findings and Implications for Stakeholders in the Animal Parvovirus Vaccine Market Ecosystem Guiding Future Strategies

In summation, this executive summary distills critical insights into the evolving animal parvovirus vaccine ecosystem. The convergence of technological innovation, shifting distribution models, and regional market dynamics highlights a landscape ripe for strategic differentiation. Notably, the impact of 2025 tariff measures has underscored the necessity for adaptable supply chain frameworks and diversified sourcing strategies, while segmentation analysis reveals nuanced customer requirements across animal types and end user categories.

Collectively, these findings illuminate pathways for industry participants to bolster resilience, enhance operational agility, and drive sustained growth. As the demand for robust immunization solutions intensifies, decision-makers are positioned to capitalize on emerging opportunities by aligning product portfolios with evolving market expectations, fostering cross-sector collaboration, and leveraging sophisticated data analytics. This synthesis of insights sets the stage for informed decision making and strategic action in the months and years ahead.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Canine
    • Feline
    • Porcine
      • Adult
      • Piglet
  • Vaccine Type
    • Inactivated
    • Live Attenuated
    • Recombinant
  • Distribution Channel
    • Offline
      • Retail Pharmacy
      • Veterinary Clinic
      • Veterinary Hospital
    • Online
  • Product Format
    • Liquid
    • Lyophilized
  • End User
    • Animal Farm
    • Veterinary Clinic
    • Veterinary Hospital
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
  • Virbac S.A.
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • HIPRA, S.A.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of novel viral vector vaccine platforms for canine parvovirus prevention
5.2. Increasing demand for combination immunization protocols against canine parvovirus and distemper
5.3. Development of thermostable parvovirus vaccines to reduce dependence on cold chain logistics in remote areas
5.4. Expansion of recombinant subunit vaccine technologies enhancing immunogenicity against feline panleukopenia virus in cats
5.5. Increasing investments in adjuvant research to boost efficacy and duration of immunity for parvovirus vaccines
5.6. Growth of public-private partnerships driving clinical trials for next generation animal parvovirus vaccines
5.7. Integration of real-time epidemiological surveillance data to optimize parvovirus vaccine distribution strategies
5.8. Emergence of oral and intranasal parvovirus vaccine formulations to improve compliance in companion animals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Animal Parvovirus Vaccine Market, by Animal Type
8.1. Introduction
8.2. Canine
8.3. Feline
8.4. Porcine
8.4.1. Adult
8.4.2. Piglet
9. Animal Parvovirus Vaccine Market, by Vaccine Type
9.1. Introduction
9.2. Inactivated
9.3. Live Attenuated
9.4. Recombinant
10. Animal Parvovirus Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.2.1. Retail Pharmacy
10.2.2. Veterinary Clinic
10.2.3. Veterinary Hospital
10.3. Online
11. Animal Parvovirus Vaccine Market, by Product Format
11.1. Introduction
11.2. Liquid
11.3. Lyophilized
12. Animal Parvovirus Vaccine Market, by End User
12.1. Introduction
12.2. Animal Farm
12.3. Veterinary Clinic
12.4. Veterinary Hospital
13. Americas Animal Parvovirus Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Animal Parvovirus Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Animal Parvovirus Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Merck & Co., Inc.
16.3.3. Boehringer Ingelheim International GmbH
16.3.4. Elanco Animal Health Incorporated
16.3.5. Ceva Santé Animale
16.3.6. Virbac S.A.
16.3.7. Vetoquinol S.A.
16.3.8. Phibro Animal Health Corporation
16.3.9. Dechra Pharmaceuticals PLC
16.3.10. HIPRA, S.A.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. ANIMAL PARVOVIRUS VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANIMAL PARVOVIRUS VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANIMAL PARVOVIRUS VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANIMAL PARVOVIRUS VACCINE MARKET: RESEARCHAI
FIGURE 26. ANIMAL PARVOVIRUS VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. ANIMAL PARVOVIRUS VACCINE MARKET: RESEARCHCONTACTS
FIGURE 28. ANIMAL PARVOVIRUS VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANIMAL PARVOVIRUS VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY CANINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY FELINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY FELINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PIGLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PIGLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL FARM, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL FARM, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 102. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 103. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 189. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. GERMANY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 192. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 193. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 203. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. FRANCE ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 220. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 221. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 222. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 223. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 224. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 225. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 228. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 229. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 230. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 231. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ITALY ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 234. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 235. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 245. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SPAIN ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 290. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 291. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 301. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. DENMARK ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 318. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 319. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2018-2024 (USD MILLION)
TABLE 320. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY PORCINE, 2025-2030 (USD MILLION)
TABLE 321. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 322. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 323. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. QATAR ANIMAL PARVOVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. QATAR ANIMAL PARVOVIRUS VAC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Animal Parvovirus Vaccine Market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
  • Virbac S.A.
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • HIPRA, S.A.

Related Topics

Related Reports

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Global Porcine Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Porcine Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Asia Pacific Veterinary Vaccine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Image

Asia Pacific Veterinary Vaccine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • 76 Pages
  • Asia Pacific
From
Veterinary Vaccines Market Report 2025 - Product Image

Veterinary Vaccines Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Europe Veterinary Vaccine Market - Growth, Trends, and Forecasts (2023-2028) - Product Image

Europe Veterinary Vaccine Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • 74 Pages
  • Europe
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.